NY-BR-1 protein was shown to be expressed in normal breast epithelia cells and in a majority of primary breast cancers [4, 5], while NY-BR-1 mRNA was detected predominantly in breast cancers [6, 7]. Here, ANKRD30A is linked to breast cancer.